Wingate Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$769K Sell
5,985
-155
-3% -$18.1K 0.34% 61
2026
Q1
$739K Sell
6,140
-537
-8% -$62K 0.39% 60
2025
Q4
$703K Buy
6,677
+1,599
+31% +$150K 0.39% 62
2025
Q3
$426K Buy
5,078
+41
+0.8% +$3.38K 0.3% 71
2025
Q2
$399K Buy
5,037
+263
+6% +$20.9K 0.36% 67
2025
Q1
$428K Buy
4,774
+11
+0.2% +$1.03K 0.49% 59
2024
Q4
$474K Buy
+4,763
New +$491K 0.47% 58

Other funds holding MRK

Wingate Wealth Advisors's MRK Position: Q2 2026 in Review

Wingate Wealth Advisors reduced its Merck (MRK) stake by 2.5% in Q2 2026, selling an estimated $18.1K and leaving 5,985 shares worth $769K. The position accounts for 0.34% of the portfolio, ranked #61.

Wingate Wealth Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Wingate Wealth Advisors held 5,985 shares of Merck worth $769K as of Q2 2026.
  • Wingate Wealth Advisors sold 155 Merck shares in Q2 2026, an estimated $18.1K.
  • Merck made up 0.34% of Wingate Wealth Advisors's portfolio in Q2 2026, its #61 holding.
  • Wingate Wealth Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wingate Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.